Nocebo effects are stronger and more persistent than placebo effects in healthy individuals
eLife · 28.10.2025 · 14
DOI: 10.7554/elife.105753 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 28.10.2025. Verfasst von Angelika Kunkel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Esse…. Hauptthemen laut MEDLINE: Nocebo Effect, Placebo Effect, Pain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Placebo and nocebo effects illustrate the profound influence of cognitive-affective processes on symptom perception and treatment outcomes, with the potential to significantly alter responses to medical interventions. Despite their clinical relevance, the question of how placebo and nocebo effects differ in strength and duration remains largely unexplored. Using a within-subject design in 104 healthy individuals, we investigated and directly compared the magnitude and persistence of placebo and nocebo effects on experimental pain. Effects were assessed immediately after their induction through verbal instructions and conditioning and at a 1-week follow-up. The study was preregistered in the German Clinical Trials Register (registration number: DRKS00029228). Significant placebo and nocebo effects were detected on days 1 and 8, but nocebo effects were stronger on both test days. Sustained effects after 1 week were primarily predicted by individuals’ experienced effects on day 1. Our findings underscore the enduring nature of placebo and nocebo effects in pain, with nocebo responses demonstrating consistently greater strength, which is consistent with an evolutionarily advantageous ‘better-safe-than-sorry’ strategy. These insights emphasise the significant impact of nocebo effects and stress the need to prioritise efforts to mitigate them in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany.
- Wellcome Centre for Integrative Neuroimaging (WIN), Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
ORCID-Profile: Angelika Kunkel, Katharina Schmidt, Helena Hartmann, Katja Wiech, Ulrike Bingel
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Kunkel, A., Schmidt, K., Hartmann, H., Strietzel, T., Sperzel, J. L., Wiech, K., & Bingel, U. (2025). Nocebo effects are stronger and more persistent than placebo effects in healthy individuals. eLife, 14. https://doi.org/10.7554/elife.105753
Vancouver
Kunkel A, Schmidt K, Hartmann H, Strietzel T, Sperzel JL, Wiech K, et al. Nocebo effects are stronger and more persistent than placebo effects in healthy individuals. eLife. 2025;14. doi:10.7554/elife.105753
BibTeX
@article{Kunkel2025,
author = {Kunkel, Angelika and Schmidt, Katharina and Hartmann, Helena and Strietzel, Torben and Sperzel, Jens-Lennart and Wiech, Katja and Bingel, Ulrike},
title = {Nocebo effects are stronger and more persistent than placebo effects in healthy individuals},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.105753}
}
EUVIMED